Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
It’s been hot in London this week. Really hot. A dangerous heat wave has hit Wes...
The initial phase of the partnership, valued at up to $15m and running until 202...
Ionis will retain the responsibility for commercialising the RNA-targeted medici...
The facility, to be located at the Board of Investment zone in Horana, will be ...
Expands Schedule H2 to include vaccines, antimicrobials and anticancer drugs Th...
Oseltamivir Phosphate is an influenza neuraminidase inhibitor (NAI) indicated f...
Raman Aulakh explores how synergistic and antagonistic tooth movements influence...
New capsule-based dental 3D printer that integrates printing and curing delivers...
The unified platform enables users to check the prices of scheduled and non-sch...
The tentative approval covers the 40 mg, 80 mg, 120 mg, and 160 mg strengths Th...
The facility has received EU GMP certification from the Malta Medicines Authori...
The company informed that the facility which is fully operational, is designed ...
From sickle cell disease to multiple sclerosis and childhood leukemia, patients ...
At a time when U.S. biotech leadership is being challenged, the patent system th...
A human‑in‑the‑loop AI framework rapidly nominates CAR T targets, leading to a G...
“The 340B drug pricing program was created to help safety net providers serve vu...
